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Basaloid squamous cell carcinoma is a highly aggressive tumor. The aim of this 
study was to present a case of a 60 year-old man having progressive hoarseness that 
lasted for six months. Indirect laryngoscopy and histopathologic examination detected 
an exophytic growth that involved the left false vocal fold. The patient underwent a left-
sided, vertical partial hemilaryngectomy. Patient had no signs of tumor recurrence or 
metastases eighteen months later. Acta Medica Medianae 2013;52(1):39-42. 
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Introduction 
 
Squamous cell carcinoma is the commo-
nest tumor of larynx, accounting for about 99% 
of laryngeal malignancies. Wain et al. in 1986 
described 10 cases of basaloid squamous cell 
carcinoma of the head and neck, hypopharynx 
and larynx (1). Basaloid squamous cell carcinoma 
is a histologically distinctive, rare, highly aggressive 
variant of squamous cell carcinoma. It is 
aggressive tumor composed of both basaloid and 
squamous components with a high mitotic index. 
This malignancy has a predilection for the upper 
aerodigestive tract, and the most common sites 
are larynx, hypopharynx, and the base of the 
tongue (2). The most frequent site of occurrence 
in the larynx is the supraglottis. Other sites 
include the floor of the mouth, tonsils, nasal 
cavity, paranasal sinuses, nasopharynx, palate, 
buccal mucosa, esophagus, and trachea (3). Histo-
logically identical tumors have been recognized at 
the anus (4), cervix uteri (5), penis (6) and urinary 
bladder (7). This malignancy generally affects 
elderly men in the sixth and seventh decades of 
life who are smokers and/or alcoholics (3). The 
clinical presentation is similar to other laryngeal 
carcinomas. Loco-regional metastases are reported 
in 64% of patients (8) and disseminated spread 
(lungs, liver, bone, brain and skin) in 22% of 
cases (9). Treatment options are radical surgery, 
chemoradiation or radiation alone. As far we 
know, very few cases of early stage basaloid 
squamous cell carcinoma have been described 
in the literature. The aim of this study was to 
present a case of early basaloid squamous cell 
carcinoma of the larynx.  
 
Case report 
 
A 60 year-old man presented with progressive 
hoarseness that lasted for six months. There 
were no complaints of difficulty in breathing or 
taking food. He had a long history of cigarette 
smoking (30-40 cigarettes/day) and alcohol 
consumption (100-150 g/day). Medical history 
was negative. Indirect laryngoscopy detected the 
presence of an ulceroexophytic growth that 
involved the left false vocal fold with preserved 
vocal cords mobility. The right endo-larynx was 
healthy and the vocal fold mobile. On physical 
examination, the patient was without a palpable 
neck mass or lymphadenopathy. A computed 
tomography (CT) scan of neck and thorax was 
negative. The patient underwent direct micro-
laryngoscopy under general anesthesia and the 
biopsy specimen was taken. Histopathologic exami-
nation identified the mass as a basaloid squamous 
cell carcinoma (Figure 1). Clinical stage: T1N0M0. 
The patient underwent a left-sided, vertical partial 
hemilaryngectomy. The surgical margins were 
free of tumor. After a follow-up period of 18 
months the patient had no signs of tumor 
recurrence or metastases as confirmed by laryn-
geal endoscopy and CT scan.  
 
Discussion 
 
Squamous cell carcinoma is the commonest 
tumor of larynx, however, verrucous, spindle cell 
and basaloid subtypes are very rare. The term Basaloid squamous cell carcinoma of the larynx: a case report                                                                             Elvir Zvrko et al. 
basaloid squamous cell carcinoma was first used 
by Wain et al. in their report of 10 cases that had 
occurred in the tongue, hypopharynx and larynx 
(1). Thankappan found 36 publications and analyzed 
100 cases related to the larynx (9). Basaloid 
squamous cell carcinoma makes up less than 1% 
of laryngeal carcinoma. 
 
 
 
Figure 1. Light microscopy revealed an invasive 
basaloid squamous cell carcinoma. (Hematoxylin-eosin 
stain, original magnification 100x) 
 
Basaloid squamous cell carcinoma arises 
from the surface epithelium and it is often deeply 
invasive due to infiltrative growth. This feature 
makes that the tumor borders are indiscreet. 
Basaloid squamous cell carcinoma originates from 
totipotential cells in the basal layer of squamous 
epithelia and is composed of both basaloid and 
squamous components (1,10). Basaloid component 
includes pleomorphic basaloid cells with hyper-
cromatic nuclei and scant cytoplasm, nuclear 
palisading at the periphery, necrosis, prominent 
hyalinisation. Squamous component includes at 
least one of the following features: adjacent foci 
of conventional squamous cell carcinoma, dys-
plasia or carcinoma in situ of the overlying 
mucosa, or focal squamous differentiation within 
a basaloid component.  
Basaloid squamous cell carcinoma expresses 
cytokeratins and a monoclonal epithelial membrane 
antigen (EMA); however, there is no specific 
immunohistochemical pattern to distinguish this 
tumor from others. However, immunohisto-
chemical markers have been reported to be 
useful in differentiating these tumors. Coletta et 
al. have demonstrated the importance of cyto-
keratins 1, 7 and 14 in the diagnosis of basaloid 
squamous cell carcinoma and have shown 
significantly higher AgNOR and PCNA positivity 
when compared with squamous cell carcinoma 
(11). Basaloid squamous cell carcinomas are 
usually negative for neuroendocrine markers 
such as chromogranin, synaptophysin and CD56, 
although S-100 protein may be weakly positive in 
some cases. The tumor is most likely to be 
confused with adenoid cystic carcinoma and 
small-cell undifferentiated carcinoma. Emanuel et 
al. have found that p63 positivity is partial in 
adenoid cystic carcinoma but diffuse in basaloid 
squamous cell carcinoma (12).  
To the best of our knowledge only few 
studies have investigated the use of oncogenic 
markers as prognostic factors in laryngeal 
basaloid squamous cell carcinoma. Salerno et al. 
found the clinical prognostic relevance of p27kip1 
low expression, which directly correlated with 
biological aggressiveness and consequent shortened 
survival (13). Rodriguez Tojo et al. found that E-
cadherin was down regulated in all 11 cases and 
the lower expression of Ki67/Mib-1 and p53 was 
related to the better prognosis (14). In contrast, 
there was no significant correlation of the levels 
of Ki67/Mib-1 and P53 status with the clinical 
findings in two small series of BSCC of the larynx 
(15, 16). Marioni et al. did not find any significant 
differences in the expression of endoglin (CD105) 
in the head and neck BSCCs and SCCs (17). 
These findings need further confirmation in large 
series and its acceptance and use in daily 
practice. 
The median age of patients with basaloid 
squamous cell carcinoma is 62 years with a range 
of 35-85 years with strong male predominance 
(96%) (9). The supraglottic location of the tumor 
is predominant and can delay the diagnosis (18). 
Our patient was 60 years old man with a supra-
glottic tumor. The clinical presentation is similar 
to the squamous cell carcinoma i.e. hoarseness 
and increasing difficulty in breathing followed by 
difficulty in taking food. It is characterized by a 
high incidence of early regional metastasis with 
45.9% nodal involvement at presentation (9). 
Winzenburg et al. showed survival of basaloid 
squamous cell carcinoma with lymph node meta-
stases of 18.6 months and significantly longer 
(47.6 months) without regional metastases (19). 
The absence of metastasis to the cervical 
lymph nodes cannot be considered to be a 
favorable prognostic sign because the tumor 
might have already spread to distant sites. 
Twenty-two percent of patients develop distant 
metastases to the lungs, liver, bones, brain, and 
skin and the lung is the predominant site (9). 
Therefore, some authors recommend an extensive 
work-up, including a chest CT and FDG-PET in all 
cases to rule out early distant metastasis. In our 
case, the patient showed no clinical or radio-
graphic evidence of lung metastasis. Seidman et al. 
and Ferlito et.al. found that patients with 
basaloid squamous cell carcinoma have the high 
risk for the development of second primary 
tumors in the upper aerodigestive tract (20, 21). 
Kunkel et al. demonstrated that FDG-PET was 
useful in the following patients with basaloid 
squamous cell carcinoma and able to detect 
clinically and radiologically invisible recurrence of 
disease (22). The global prognosis of this type of 
tumor tends to be poor due to their presentation 
in advanced stages. Basaloid squamous cell 
carcinoma is a highly aggressive tumor with the 
overall five-year survival rate as 47.5% (9).  
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There is no established consensus for 
treatment. Treatment consists of radical surgery, 
radiotherapy, or both, with or without chemo-
therapy. According to literature, total laryngectomy 
is the commonest surgery reported. When diagnosed 
at an early stage, partial surgery can be used. In 
our case, the patient was treated only with surgery 
because all of the surgical margins were tumor-
free and some of previous studies stressed that 
an early stage of tumor can be treated more 
conservatively. Our patient did not receive additional 
radiotherapy due to their initial stage without 
lymph node affectation. Erdamar et al. suggest 
regimens incorporating radiotherapy and chemo-
therapy taking into consideration the high risk of 
regional and distant metastasis and tendency for 
the development of second primary tumors (23).  
 
Conclusion 
 
Basaloid squamous cell carcinoma is a 
distinct clinicopathological entity with aggressive 
clinical behavior. Basaloid squamous cell carci-
noma preferentially occurs in the head and neck 
region. Very often, it is diagnosed at advanced 
clinical stages and has an unfavorable prognosis 
because of poor overall patient survival rate. The 
generally recommended treatment options for 
basaloid squamous cell carcinoma of larynx 
include complete surgical excision supplemented 
with radiotherapy. A larger number of patients 
must be studied to provide the best possible 
evidence and recommend the appropriate 
treatment.  
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BAZALOIDNI SKVAMOCELULARNI KARCINOM LARINKSA: PRIKAZ 
BOLESNIKA 
 
Elvir Zvrko, Vladan Knežević i Mileta Golubović 
 
 
Bazaloidni skvamocelularni karcinom je vrlo agresivan tumor. Cilj ovog rada bio 
je da prikažemo bolesnika muškog pola, starog 60 godina, koji se javio zbog 
progredirajuće promuklosti koja je trajala oko 6 mjeseci. Indirektnom laringoskopijom i 
patohistološkim pregledom potvrđeno je prisustvo egzofitičnog tumora na lijevom 
ventrikularnom naboru. Kod bolesnika je urađena lijeva vertikalna hemilaringektomija. 
Nakon 18 mjeseci od završenog liječenja, bolesnik je bez znakova za postojanje 
recidiva bolesti i bez udaljenih metastaza. Acta Medica Medianae 2013;52(1):39-42. 
 
Ključne reči: karcinom larinksa, bazaloidni tip, laringektomija 